Martin Fan
Stock Analyst at Wedbush
(4.90)
# 238
Out of 4,468 analysts
54
Total ratings
80.5%
Success rate
81.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Martin Fan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RNAC Cartesian Therapeutics | Maintained: Buy | $38 | $10.59 | +258.83% | 6 | Jun 10, 2026 | |
| ARTV Artiva Biotherapeutics | Maintained: Buy | $40 | $9.61 | +316.23% | 4 | May 21, 2026 | |
| TRAX First Tracks Biotherapeutics | Maintained: Buy | $30 | $19.30 | +55.44% | 2 | May 15, 2026 | |
| FATE Fate Therapeutics | Maintained: Buy | $7 | $2.92 | +139.73% | 4 | May 14, 2026 | |
| VOR Vor Biopharma | Maintained: Hold | $15 → $18 | $20.59 | -12.58% | 3 | May 14, 2026 | |
| SANA Sana Biotechnology | Maintained: Buy | $7 | $4.01 | +74.56% | 4 | May 13, 2026 | |
| NKTR Nektar Therapeutics | Maintained: Hold | $95 → $80 | $71.04 | +12.61% | 3 | May 11, 2026 | |
| IMA ImageneBio | Maintained: Sell | $2 | $5.66 | -64.66% | 3 | May 11, 2026 | |
| ACRS Aclaris Therapeutics | Maintained: Buy | $10 | $5.56 | +79.86% | 7 | May 8, 2026 | |
| ZURA Zura Bio | Maintained: Buy | $15 | $5.17 | +190.14% | 3 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $85 | $85.21 | -0.25% | 6 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $27.23 | +65.26% | 6 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $39.88 | +15.35% | 1 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $45 | $63.42 | -29.04% | 2 | Aug 7, 2025 |
Cartesian Therapeutics
Jun 10, 2026
Maintained: Buy
Price Target: $38
Current: $10.59
Upside: +258.83%
Artiva Biotherapeutics
May 21, 2026
Maintained: Buy
Price Target: $40
Current: $9.61
Upside: +316.23%
First Tracks Biotherapeutics
May 15, 2026
Maintained: Buy
Price Target: $30
Current: $19.30
Upside: +55.44%
Fate Therapeutics
May 14, 2026
Maintained: Buy
Price Target: $7
Current: $2.92
Upside: +139.73%
Vor Biopharma
May 14, 2026
Maintained: Hold
Price Target: $15 → $18
Current: $20.59
Upside: -12.58%
Sana Biotechnology
May 13, 2026
Maintained: Buy
Price Target: $7
Current: $4.01
Upside: +74.56%
Nektar Therapeutics
May 11, 2026
Maintained: Hold
Price Target: $95 → $80
Current: $71.04
Upside: +12.61%
ImageneBio
May 11, 2026
Maintained: Sell
Price Target: $2
Current: $5.66
Upside: -64.66%
Aclaris Therapeutics
May 8, 2026
Maintained: Buy
Price Target: $10
Current: $5.56
Upside: +79.86%
Zura Bio
May 8, 2026
Maintained: Buy
Price Target: $15
Current: $5.17
Upside: +190.14%
Apr 15, 2026
Maintained: Buy
Price Target: $45 → $85
Current: $85.21
Upside: -0.25%
Mar 17, 2026
Maintained: Buy
Price Target: $45
Current: $27.23
Upside: +65.26%
Feb 26, 2026
Reiterated: Buy
Price Target: $46
Current: $39.88
Upside: +15.35%
Aug 7, 2025
Maintained: Buy
Price Target: $40 → $45
Current: $63.42
Upside: -29.04%